CD146 is a novel marker for highly tumorigenic cells and a potential therapeutic target in malignant rhabdoid tumor

Malignant rhabdoid tumor (MRT) is a rare, highly aggressive pediatric malignancy that primarily develops during infancy and early childhood. Despite the existing standard of intensive multimodal therapy, the prognosis of patients with MRT is dismal; therefore, a greater understanding of the biology...

Descripción completa

Detalles Bibliográficos
Autores principales: Nodomi, S, Umeda, K, Saida, S, Kinehara, T, Hamabata, T, Daifu, T, Kato, I, Hiramatsu, H, Watanabe, K-i, Kuwahara, Y, Iehara, T, Adachi, S, Konishi, E, Nakahata, T, Hosoi, H, Heike, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057042/
https://www.ncbi.nlm.nih.gov/pubmed/27041577
http://dx.doi.org/10.1038/onc.2016.72

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057042/
https://www.ncbi.nlm.nih.gov/pubmed/27041577
http://dx.doi.org/10.1038/onc.2016.72

Ejemplares similares